OpenAlex
PricingAboutJobs
Log inGet started
Work

Covalent Docking Identifies a Potent and Selective MKK7 Inhibitor

HTML PDF

Year: 2018
Type: article
Source: Cell chemical biology
DOI: 10.1016/j.chembiol.2018.10.011
Authors: Amit Shraga, Evgenia Olshvang, Natalia Davidzohn, Payam Khoshkenar, Nicolas Germain, Khriesto Shurrush, Silvia Carvalho, Liat Avram, Shira Albeck, Tamar Unger, Bruce Lefker, Chakrapani Subramanyam, Robert L. Hudkins, Amir Mitchell, Ziv Shulman, Takayoshi Kinoshita, Nir London
Institutions: Weizmann Institute of Science, University of Massachusetts Chan Medical School, Pfizer (United States), Teva Pharmaceuticals (United States), Osaka Prefecture University
Language: English

Topic: Computational Drug Discovery Methods
Subfield: Drug Discovery
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: MKK7, JNK signaling, kinase inhibitors, MEK, JNK phosphorylation, kinase selectivity, B cell activation, lipopolysaccharide, covalent docking

Open Access status: bronze

Funders: Teva Pharmaceutical Industries, Israel Science Foundation, Institute for Protein Research, Osaka University
Award: G431548031
OpenAlex ID: W2900458600
FWCI: 2.759
Cites: 79
Cited by: 69
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security